drugset / Trial / NCT02894840
Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults
Phase 1/2
Completed
340 enrolled
Mahidol University
The Government Pharmaceutical Organization · collabWorld Health Organization · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The study is aim to evaluate the safety and immunogenicity of one dose (15 μg HA per strain per dose) of the GPO seasonal trivalent inactivated split virion influenza vaccine (Tri Fluvac) in healthy adults aged 18 to 49 years over 90 days post-injection.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-07
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tri Fluvac | Vaccine | 15 ug | Intramuscular |